EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance

Xiaolong Chen iD, Zhen Wang, Yangsheng Rong, Zhiqiang Zhu, Zheng Peng, Kunyuan Huang, Guanyun Deng, Di Liu, Qing Wang, Jianguo Zhu, Kun Chen, Kehua Jiang iD

PLOS One · 08.06.2026 · 21 (6) · e0347623

DOI: 10.1371/journal.pone.0347623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.06.2026. Verfasst von Xiaolong Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tumor Microenvironment, Epithelial-Mesenchymal Transition, Cell Adhesion Molecules. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: he project of National Natural Science Foundation of China, Science and Technology Fund Project of Guizhou Provincial Health Commission, the Project of Scientific and Technological Research of Traditional Chinese Medicine and Ethnic Medicine in Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bladder cancer, the most common malignancy of the urinary system, is associated with poor prognosis due to its metastatic potential, invasive behavior, and immune evasion. Intercellular adhesion molecule 5 (ICAM5), a member of the immunoglobulin superfamily, regulates cell adhesion and has been implicated in tumor progression. However, its biological function in bladder cancer remains unclear.

Methods

In this study, we analyzed data from The Cancer Genome Atlas (TCGA) and UCSC Xena databases to investigate ICAM5 expression, prognostic significance, genetic mutations, methylation, immune profiles, and regulatory functions in bladder cancer. Weighted Gene Coexpression Network Analysis (WGCNA) and Gene Set Cancer Analysis (GSCA) were employed to explore ICAM5-related pathways.

Results

Our findings demonstrated that ICAM5 expression was significantly upregulated in bladder cancer and associated with advanced disease features, including higher TNM stages, pathological grades, and aggressive molecular subtypes. Furthermore, ICAM5 influenced the immune microenvironment, regulated methylation, and modulated immune checkpoint expression, contributing to immunotherapy resistance. Mechanistically, ICAM5 promoted epithelial-mesenchymal transition (EMT), proliferation, and metastasis.

Conclusions

ICAM5 serves as a novel prognostic biomarker and potential therapeutic target in bladder cancer, orchestrating EMT progression, reshaping the immune microenvironment, and driving resistance to immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsTumor MicroenvironmentEpithelial-Mesenchymal TransitionCell Adhesion MoleculesDrug Resistance, NeoplasmHumansPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticFemaleMaleDNA MethylationCell Line, Tumor

Substanzen

Biomarkers, TumorCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Department of Urology, Weng'an County People's Hospital, Guizhou, China.
  • Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Urology, People's Hospital of Qiandongnan Miao and Dong Autonomous Prefecture, Kaili.
  • Department of Medical Genetics, Guizhou Provincial People's Hospital, Guiyang, China.

ORCID-Profile: Xiaolong Chen, Kehua Jiang

Förderung

  • he project of National Natural Science Foundation of China
  • Science and Technology Fund Project of Guizhou Provincial Health Commission
  • the Project of Scientific and Technological Research of Traditional Chinese Medicine and Ethnic Medicine in Guizhou Province

Zitieren

APA

Chen, X., Wang, Z., Rong, Y., Zhu, Z., Peng, Z., Huang, K., Deng, G., Liu, D., Wang, Q., Zhu, J., Chen, K., & Jiang, K. (2026). Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance. PLOS One, 21(6), e0347623. https://doi.org/10.1371/journal.pone.0347623

Vancouver

Chen X, Wang Z, Rong Y, Zhu Z, Peng Z, Huang K, et al. Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance. PLOS One. 2026;21(6):e0347623. doi:10.1371/journal.pone.0347623

BibTeX
@article{Chen2026,
  author = {Chen, Xiaolong and Wang, Zhen and Rong, Yangsheng and Zhu, Zhiqiang and Peng, Zheng and Huang, Kunyuan and Deng, Guanyun and Liu, Di and Wang, Qing and Zhu, Jianguo and Chen, Kun and Jiang, Kehua},
  title = {Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0347623},
  doi = {10.1371/journal.pone.0347623}
}
Kostenlos starten →